Herbas VPB

Print
EN | LT
LT - Anti-CD38 antikūnas ir lenalidomidas arba bortezomibas, skirti išsėtinės mielomos ir NHL (neHodžkino limfoma) gydymui
EN - ANTI-CD38 ANTIBODY AND LENALIDOMIDE OR BORTEZOMIB FOR THE TREATMENT OF MULTIPLE MYELOMA AND NHL

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395 (2006.01)
A61K 38/05 (2006.01)
A61K 38/07 (2006.01)
A61K 45/06 (2006.01)
A61K 31/454 (2006.01)
C07K 16/30 (2006.01)
C07K 16/28 (2006.01)
A61P 35/00 (2006.01)
A61K 31/69 (2006.01)
European patent
(11) Number of the document 2621531
(13) Kind of document T
(96) European patent application number 11761360.4
Date of filing the European patent application 2011-09-26
(97) Date of publication of the European application 2013-08-07
(45) Date of publication and mention of the grant of the patent 2016-11-30
(46) Date of publication of the claims translation 2017-04-10
PCT application
(86) Number PCT/EP2011/066648
Date 2011-09-26
PCT application publication
(87) Number WO 2012/041800
Date 2012-04-05
Priority applications
(30) Number Date Country code
201161486814 P 2011-05-17 US
201161468607 P 2011-03-29 US
201161437696 P 2011-01-31 US
386619 P 2010-09-27 US
10180485 2010-09-27 EP
Inventors
(72)
ROJKJAER, Lisa, CH
BOXHAMMER, Rainer, DE
ENDELL, Jan, DE
WINDERLICH, Mark, DE
SAMUELSSON, Christofer, DE
Grantee
(73) MorphoSys AG, Lena-Christ-Strasse 48, 82152 Martinsried/Planegg, DE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Anti-CD38 antikūnas ir lenalidomidas arba bortezomibas, skirti išsėtinės mielomos ir NHL (neHodžkino limfoma) gydymui
  ANTI-CD38 ANTIBODY AND LENALIDOMIDE OR BORTEZOMIB FOR THE TREATMENT OF MULTIPLE MYELOMA AND NHL
Last renewal fee
Payment date Validity (years) Amount
2024-09-02 14 289.00 EUR
Next renewal fee
2025-09-26